Enact funds the long repair job
- Genworth's main value driver is its 81% stake in Enact, a public mortgage insurer expecting to return up to $485 million to the parent in 2026.
- The Closed Block matters because legacy long-term care policies can create losses, with recent actual-to-expected claim losses running hot in early 2026.
- The long-term care rate action plan has reached about $34.8 billion of cumulative economic benefit, easing some balance sheet pressure.
- CareScout is the growth bet, though its services arm is currently pacing below volume targets ahead of a key worksite product launch.
- The company is navigating an interim leadership structure following a medical leave of absence for its CEO in mid-2026.
A valuable stake and older risks
Genworth is a sum of parts story. The cleanest part is Enact, its majority-owned mortgage insurance company. Enact is profitable, public, and raised its capital return expectations for 2026 to a midpoint of $465 million. This cash allows Genworth to fund a share repurchase target of up to $250 million for the year.
The hard part is the Closed Block. This is the old long-term care, life, and annuity business that Genworth no longer actively sells. The company has worked for years to raise premiums on older long-term care policies. That plan has produced $34.8 billion of cumulative economic benefit through the second quarter of 2026, but management still has roughly $5.0 billion left to achieve.
The bull case is that investors give Genworth more credit for Enact and less punishment for the Closed Block over time. CareScout adds a possible growth leg, especially if Care Assurance can bring in real revenue with its worksite launch later in 2026.
The bear case remains tied to execution and legacy liabilities. The Closed Block saw claim losses run hotter than expected in early 2026. Furthermore, the CEO taking a medical leave introduces execution uncertainty, and the CareScout services business is pacing behind its volume targets.
Cash from mortgages, risk from care
Genworth makes money mostly from insurance premiums and investment income. The business is formally segmented to separate the profitable ongoing operations from the legacy risks.
Enact sells private mortgage insurance. Lenders use this insurance when a borrower has a smaller down payment. Enact earns premiums, pays claims when insured borrowers default, and returns excess capital through dividends and buybacks.
The Closed Block is different. It is a runoff book, meaning Genworth is not trying to grow it. It is trying to make sure the old policies can pay claims without needing fresh parent capital. That depends on reserves, investment returns, claims experience, and more rate approvals from state regulators.
CareScout sits in Corporate and Other. It offers fee-based aging care services and a newer long-term care insurance product called Care Assurance. The idea is to build a lower-risk aging care platform, but it is still early and consuming cash as the company works to scale it.
What Genworth sells or manages
Enact mortgage insurance
Enact provides private mortgage insurance to lenders and investors. It is the main earnings engine and is expected to return up to $485 million to Genworth Holdings in 2026.
CareScout aging care services
CareScout offers fee-based aging care support through the CareScout Quality Network, though match volumes are currently pacing behind targets.
SeniorLeaf senior living placement
SeniorLeaf adds senior living placement to CareScout's home care network. The key question is whether the acquired platform can generate meaningful revenue.
CareScout Care Assurance
Care Assurance is Genworth's newer long-term care insurance product, launched in late 2025. A worksite version is set to launch in the third quarter of 2026.
Legacy long-term care insurance
This is the largest and most sensitive part of the Closed Block. Genworth no longer actively sells these old policies, but it must keep paying valid claims.
Legacy life insurance and annuities
These are older in-force blocks that are also in runoff. They can still affect earnings, capital, and reported volatility.
Mix highlights the legacy drag
Segment shares use Q1 2026 total revenue disclosed in the Form 10-Q. Revenue mix does not equal value mix, since Enact produces positive operating income while the Closed Block often loses money.
What could break the thesis
Closed Block claim losses worsen
High impact · Medium oddsThe old long-term care policies are the main balance sheet risk. Actual-to-expected losses ran hotter than expected in the first half of 2026. If claim frequency or severity structurally shifts higher, losses could grow.
Leadership transition uncertainty
Medium impact · Medium oddsThe CEO took a medical leave of absence in mid-2026, putting an interim structure in place. This introduces potential delays or shifts in strategic execution and capital allocation.
Enact capital returns slow
High impact · Medium oddsGenworth relies on Enact to send cash to the holding company. A housing downturn, higher unemployment, or mortgage insurance capital rules could reduce Enact's ability to send money up.
CareScout burns cash without scale
Medium impact · Medium oddsCareScout is the growth story, but it is missing match volume targets. If customer demand remains weak, the business may stay costly for longer without generating a return.
In one breath
Why is Genworth stock tied to Enact?
Genworth owns a majority stake in Enact, a public mortgage insurer. Enact is the clearest source of profit and parent-company cash, expecting to return up to $485 million in 2026.
What is the Closed Block at Genworth?
The Closed Block is Genworth's old long-term care, life, and annuity business. These policies are no longer actively sold, but they still create claims, reserves, and earnings risk.
What is CareScout?
CareScout is Genworth's aging care growth platform. It includes care services, a provider network, senior living placement through SeniorLeaf, and the newer Care Assurance long-term care product.
What should investors watch next?
Watch Enact capital returns, long-term care claim loss trends, and early Care Assurance worksite sales data. The leadership transition is also a key monitorable.
